See also this year's filing and all EDGAR filings for this company.
PDF Report 0001328143_2016_Adamas_Pharmaceuticals_Inc.pdf
Logs
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001328143, Adamas Pharmaceuticals Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 113,187,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 2,353,000 |
| 3 | remainder_Assets | 13,203,000 |
| 4 | LiabilitiesCurrent | 11,807,000 |
| 5 | LiabilitiesNoncurrent | 749,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 23,458,000 |
| 9 | ResearchAndDevelopmentExpense | 35,895,000 |
| 10 | remainder_Expenses | -5,635,000 |
| 11 | remainder_Revenues | 1,916,000 |
| 12 | remainder_NetIncome | 0 |
| 13 | remainder_ComprehensiveNetIncome | 22,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 128,743,000 |
| 1 | Liabilities | 12,556,000 |
| 2 | Expenses | 53,718,000 |
| 3 | Revenues | 1,916,000 |
| 4 | StockholdersEquity | 116,187,000 |
| 5 | NetIncome | -51,802,000 |
| 6 | ComprehensiveNetIncome | -51,791,000 |
| 7 | BaseVar | 98,477,500 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 2.85 |
| 9 | EconomicCapitalRatio | 3.59 |
Edgar->Model Mapping
Feature Distribution
Change over Time
